Pharma & Healthcare
Global Icosapent Ethyl Drugs Market Research Report 2026
- Feb 24, 26
- ID: 717563
- Pages: 133
- Figures: 137
- Views: 3
This report delivers a comprehensive overview of the global Icosapent Ethyl Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Icosapent Ethyl Drugs. The Icosapent Ethyl Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Icosapent Ethyl Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Icosapent Ethyl Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Woodward Pharma
Amarin Pharmaceuticals
Apotex
Hikma
Dr. Reddy's Laboratories
Teva
Ascent Pharmaceuticals
Zydus
Strides Pharma
PuraCap Pharmaceuticals
Sun Pharma
Mankind Pharma
Amneal Pharmaceuticals
GLW Pharma
Sichuan Gowell Pharmaceutical
Qilu Pharmaceutical
Chengdu Suncadia Medicine
Jiangsu Wangao Pharmaceutical
Humanwell Puracap Pharmaceuticals
Segment by Type
Single Drug
Combination Drug
by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Icosapent Ethyl Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Icosapent Ethyl Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Icosapent Ethyl Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Icosapent Ethyl Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Woodward Pharma
Amarin Pharmaceuticals
Apotex
Hikma
Dr. Reddy's Laboratories
Teva
Ascent Pharmaceuticals
Zydus
Strides Pharma
PuraCap Pharmaceuticals
Sun Pharma
Mankind Pharma
Amneal Pharmaceuticals
GLW Pharma
Sichuan Gowell Pharmaceutical
Qilu Pharmaceutical
Chengdu Suncadia Medicine
Jiangsu Wangao Pharmaceutical
Humanwell Puracap Pharmaceuticals
Segment by Type
Single Drug
Combination Drug
by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Icosapent Ethyl Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Icosapent Ethyl Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Icosapent Ethyl Drugs Market Overview
1.1 Product Definition
1.2 Icosapent Ethyl Drugs by Type
1.2.1 Global Icosapent Ethyl Drugs Market Value by Type: 2025 vs 2032
1.2.2 Single Drug
1.2.3 Combination Drug
1.3 Icosapent Ethyl Drugs by Application
1.3.1 Global Icosapent Ethyl Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Icosapent Ethyl Drugs Market Size Estimates and Forecasts
1.4.1 Global Icosapent Ethyl Drugs Revenue 2021–2032
1.4.2 Global Icosapent Ethyl Drugs Sales 2021–2032
1.4.3 Global Icosapent Ethyl Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Icosapent Ethyl Drugs Market Competition by Manufacturers
2.1 Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Icosapent Ethyl Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Icosapent Ethyl Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Icosapent Ethyl Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Icosapent Ethyl Drugs, Date of Entry into the Industry
2.8 Global Icosapent Ethyl Drugs Market Competitive Situation and Trends
2.8.1 Global Icosapent Ethyl Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Icosapent Ethyl Drugs Players Market Share by Revenue
2.8.3 Global Icosapent Ethyl Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Icosapent Ethyl Drugs Market Scenario by Region
3.1 Global Icosapent Ethyl Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Icosapent Ethyl Drugs Sales by Region: 2021–2032
3.2.1 Global Icosapent Ethyl Drugs Sales by Region: 2021–2026
3.2.2 Global Icosapent Ethyl Drugs Sales by Region: 2027–2032
3.3 Global Icosapent Ethyl Drugs Revenue by Region: 2021–2032
3.3.1 Global Icosapent Ethyl Drugs Revenue by Region: 2021–2026
3.3.2 Global Icosapent Ethyl Drugs Revenue by Region: 2027–2032
3.4 North America Icosapent Ethyl Drugs Market Facts & Figures by Country
3.4.1 North America Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.4.3 North America Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icosapent Ethyl Drugs Market Facts & Figures by Country
3.5.1 Europe Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.5.3 Europe Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icosapent Ethyl Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Icosapent Ethyl Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Icosapent Ethyl Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Icosapent Ethyl Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Icosapent Ethyl Drugs Market Facts & Figures by Country
3.7.1 Latin America Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.7.3 Latin America Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Icosapent Ethyl Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Icosapent Ethyl Drugs Sales by Type (2021–2032)
4.1.1 Global Icosapent Ethyl Drugs Sales by Type (2021–2026)
4.1.2 Global Icosapent Ethyl Drugs Sales by Type (2027–2032)
4.1.3 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021–2032)
4.2 Global Icosapent Ethyl Drugs Revenue by Type (2021–2032)
4.2.1 Global Icosapent Ethyl Drugs Revenue by Type (2021–2026)
4.2.2 Global Icosapent Ethyl Drugs Revenue by Type (2027–2032)
4.2.3 Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Icosapent Ethyl Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Icosapent Ethyl Drugs Sales by Application (2021–2032)
5.1.1 Global Icosapent Ethyl Drugs Sales by Application (2021–2026)
5.1.2 Global Icosapent Ethyl Drugs Sales by Application (2027–2032)
5.1.3 Global Icosapent Ethyl Drugs Sales Market Share by Application (2021–2032)
5.2 Global Icosapent Ethyl Drugs Revenue by Application (2021–2032)
5.2.1 Global Icosapent Ethyl Drugs Revenue by Application (2021–2026)
5.2.2 Global Icosapent Ethyl Drugs Revenue by Application (2027–2032)
5.2.3 Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Icosapent Ethyl Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Woodward Pharma
6.1.1 Woodward Pharma Company Information
6.1.2 Woodward Pharma Description and Business Overview
6.1.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
6.1.5 Woodward Pharma Recent Developments/Updates
6.2 Amarin Pharmaceuticals
6.2.1 Amarin Pharmaceuticals Company Information
6.2.2 Amarin Pharmaceuticals Description and Business Overview
6.2.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.2.5 Amarin Pharmaceuticals Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Company Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Apotex Icosapent Ethyl Drugs Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hikma Icosapent Ethyl Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Icosapent Ethyl Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Ascent Pharmaceuticals
6.7.1 Ascent Pharmaceuticals Company Information
6.7.2 Ascent Pharmaceuticals Description and Business Overview
6.7.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.7.5 Ascent Pharmaceuticals Recent Developments/Updates
6.8 Zydus
6.8.1 Zydus Company Information
6.8.2 Zydus Description and Business Overview
6.8.3 Zydus Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zydus Icosapent Ethyl Drugs Product Portfolio
6.8.5 Zydus Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 PuraCap Pharmaceuticals
6.10.1 PuraCap Pharmaceuticals Company Information
6.10.2 PuraCap Pharmaceuticals Description and Business Overview
6.10.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.10.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Mankind Pharma
6.12.1 Mankind Pharma Company Information
6.12.2 Mankind Pharma Description and Business Overview
6.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
6.12.5 Mankind Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 GLW Pharma
6.14.1 GLW Pharma Company Information
6.14.2 GLW Pharma Description and Business Overview
6.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
6.14.5 GLW Pharma Recent Developments/Updates
6.15 Sichuan Gowell Pharmaceutical
6.15.1 Sichuan Gowell Pharmaceutical Company Information
6.15.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.15.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.15.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Chengdu Suncadia Medicine
6.17.1 Chengdu Suncadia Medicine Company Information
6.17.2 Chengdu Suncadia Medicine Description and Business Overview
6.17.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
6.17.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.18 Jiangsu Wangao Pharmaceutical
6.18.1 Jiangsu Wangao Pharmaceutical Company Information
6.18.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.18.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.18.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.19 Humanwell Puracap Pharmaceuticals
6.19.1 Humanwell Puracap Pharmaceuticals Company Information
6.19.2 Humanwell Puracap Pharmaceuticals Description and Business Overview
6.19.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.19.5 Humanwell Puracap Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Icosapent Ethyl Drugs Industry Chain Analysis
7.2 Icosapent Ethyl Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icosapent Ethyl Drugs Production Mode & Process Analysis
7.4 Icosapent Ethyl Drugs Sales and Marketing
7.4.1 Icosapent Ethyl Drugs Sales Channels
7.4.2 Icosapent Ethyl Drugs Distributors
7.5 Icosapent Ethyl Drugs Customer Analysis
8 Icosapent Ethyl Drugs Market Dynamics
8.1 Icosapent Ethyl Drugs Industry Trends
8.2 Icosapent Ethyl Drugs Market Drivers
8.3 Icosapent Ethyl Drugs Market Challenges
8.4 Icosapent Ethyl Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Icosapent Ethyl Drugs by Type
1.2.1 Global Icosapent Ethyl Drugs Market Value by Type: 2025 vs 2032
1.2.2 Single Drug
1.2.3 Combination Drug
1.3 Icosapent Ethyl Drugs by Application
1.3.1 Global Icosapent Ethyl Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Icosapent Ethyl Drugs Market Size Estimates and Forecasts
1.4.1 Global Icosapent Ethyl Drugs Revenue 2021–2032
1.4.2 Global Icosapent Ethyl Drugs Sales 2021–2032
1.4.3 Global Icosapent Ethyl Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Icosapent Ethyl Drugs Market Competition by Manufacturers
2.1 Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Icosapent Ethyl Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Icosapent Ethyl Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Icosapent Ethyl Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Icosapent Ethyl Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Icosapent Ethyl Drugs, Date of Entry into the Industry
2.8 Global Icosapent Ethyl Drugs Market Competitive Situation and Trends
2.8.1 Global Icosapent Ethyl Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Icosapent Ethyl Drugs Players Market Share by Revenue
2.8.3 Global Icosapent Ethyl Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Icosapent Ethyl Drugs Market Scenario by Region
3.1 Global Icosapent Ethyl Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Icosapent Ethyl Drugs Sales by Region: 2021–2032
3.2.1 Global Icosapent Ethyl Drugs Sales by Region: 2021–2026
3.2.2 Global Icosapent Ethyl Drugs Sales by Region: 2027–2032
3.3 Global Icosapent Ethyl Drugs Revenue by Region: 2021–2032
3.3.1 Global Icosapent Ethyl Drugs Revenue by Region: 2021–2026
3.3.2 Global Icosapent Ethyl Drugs Revenue by Region: 2027–2032
3.4 North America Icosapent Ethyl Drugs Market Facts & Figures by Country
3.4.1 North America Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.4.3 North America Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icosapent Ethyl Drugs Market Facts & Figures by Country
3.5.1 Europe Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.5.3 Europe Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icosapent Ethyl Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Icosapent Ethyl Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Icosapent Ethyl Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Icosapent Ethyl Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Icosapent Ethyl Drugs Market Facts & Figures by Country
3.7.1 Latin America Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.7.3 Latin America Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Icosapent Ethyl Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Icosapent Ethyl Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Icosapent Ethyl Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Icosapent Ethyl Drugs Sales by Type (2021–2032)
4.1.1 Global Icosapent Ethyl Drugs Sales by Type (2021–2026)
4.1.2 Global Icosapent Ethyl Drugs Sales by Type (2027–2032)
4.1.3 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021–2032)
4.2 Global Icosapent Ethyl Drugs Revenue by Type (2021–2032)
4.2.1 Global Icosapent Ethyl Drugs Revenue by Type (2021–2026)
4.2.2 Global Icosapent Ethyl Drugs Revenue by Type (2027–2032)
4.2.3 Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Icosapent Ethyl Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Icosapent Ethyl Drugs Sales by Application (2021–2032)
5.1.1 Global Icosapent Ethyl Drugs Sales by Application (2021–2026)
5.1.2 Global Icosapent Ethyl Drugs Sales by Application (2027–2032)
5.1.3 Global Icosapent Ethyl Drugs Sales Market Share by Application (2021–2032)
5.2 Global Icosapent Ethyl Drugs Revenue by Application (2021–2032)
5.2.1 Global Icosapent Ethyl Drugs Revenue by Application (2021–2026)
5.2.2 Global Icosapent Ethyl Drugs Revenue by Application (2027–2032)
5.2.3 Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Icosapent Ethyl Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Woodward Pharma
6.1.1 Woodward Pharma Company Information
6.1.2 Woodward Pharma Description and Business Overview
6.1.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
6.1.5 Woodward Pharma Recent Developments/Updates
6.2 Amarin Pharmaceuticals
6.2.1 Amarin Pharmaceuticals Company Information
6.2.2 Amarin Pharmaceuticals Description and Business Overview
6.2.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.2.5 Amarin Pharmaceuticals Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Company Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Apotex Icosapent Ethyl Drugs Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Company Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hikma Icosapent Ethyl Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Icosapent Ethyl Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Ascent Pharmaceuticals
6.7.1 Ascent Pharmaceuticals Company Information
6.7.2 Ascent Pharmaceuticals Description and Business Overview
6.7.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.7.5 Ascent Pharmaceuticals Recent Developments/Updates
6.8 Zydus
6.8.1 Zydus Company Information
6.8.2 Zydus Description and Business Overview
6.8.3 Zydus Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zydus Icosapent Ethyl Drugs Product Portfolio
6.8.5 Zydus Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Company Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 PuraCap Pharmaceuticals
6.10.1 PuraCap Pharmaceuticals Company Information
6.10.2 PuraCap Pharmaceuticals Description and Business Overview
6.10.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.10.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Mankind Pharma
6.12.1 Mankind Pharma Company Information
6.12.2 Mankind Pharma Description and Business Overview
6.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
6.12.5 Mankind Pharma Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 GLW Pharma
6.14.1 GLW Pharma Company Information
6.14.2 GLW Pharma Description and Business Overview
6.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
6.14.5 GLW Pharma Recent Developments/Updates
6.15 Sichuan Gowell Pharmaceutical
6.15.1 Sichuan Gowell Pharmaceutical Company Information
6.15.2 Sichuan Gowell Pharmaceutical Description and Business Overview
6.15.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.15.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates
6.16 Qilu Pharmaceutical
6.16.1 Qilu Pharmaceutical Company Information
6.16.2 Qilu Pharmaceutical Description and Business Overview
6.16.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.16.5 Qilu Pharmaceutical Recent Developments/Updates
6.17 Chengdu Suncadia Medicine
6.17.1 Chengdu Suncadia Medicine Company Information
6.17.2 Chengdu Suncadia Medicine Description and Business Overview
6.17.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
6.17.5 Chengdu Suncadia Medicine Recent Developments/Updates
6.18 Jiangsu Wangao Pharmaceutical
6.18.1 Jiangsu Wangao Pharmaceutical Company Information
6.18.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
6.18.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
6.18.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.19 Humanwell Puracap Pharmaceuticals
6.19.1 Humanwell Puracap Pharmaceuticals Company Information
6.19.2 Humanwell Puracap Pharmaceuticals Description and Business Overview
6.19.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
6.19.5 Humanwell Puracap Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Icosapent Ethyl Drugs Industry Chain Analysis
7.2 Icosapent Ethyl Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icosapent Ethyl Drugs Production Mode & Process Analysis
7.4 Icosapent Ethyl Drugs Sales and Marketing
7.4.1 Icosapent Ethyl Drugs Sales Channels
7.4.2 Icosapent Ethyl Drugs Distributors
7.5 Icosapent Ethyl Drugs Customer Analysis
8 Icosapent Ethyl Drugs Market Dynamics
8.1 Icosapent Ethyl Drugs Industry Trends
8.2 Icosapent Ethyl Drugs Market Drivers
8.3 Icosapent Ethyl Drugs Market Challenges
8.4 Icosapent Ethyl Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Icosapent Ethyl Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Icosapent Ethyl Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Icosapent Ethyl Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Icosapent Ethyl Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Icosapent Ethyl Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Icosapent Ethyl Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Icosapent Ethyl Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Icosapent Ethyl Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icosapent Ethyl Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Icosapent Ethyl Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Icosapent Ethyl Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Icosapent Ethyl Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Icosapent Ethyl Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Icosapent Ethyl Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Icosapent Ethyl Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Icosapent Ethyl Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Icosapent Ethyl Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Icosapent Ethyl Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Woodward Pharma Company Information
Table 71. Woodward Pharma Description and Business Overview
Table 72. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Woodward Pharma Icosapent Ethyl Drugs Product
Table 74. Woodward Pharma Recent Developments/Updates
Table 75. Amarin Pharmaceuticals Company Information
Table 76. Amarin Pharmaceuticals Description and Business Overview
Table 77. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product
Table 79. Amarin Pharmaceuticals Recent Developments/Updates
Table 80. Apotex Company Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Apotex Icosapent Ethyl Drugs Product
Table 84. Apotex Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hikma Icosapent Ethyl Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Icosapent Ethyl Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Ascent Pharmaceuticals Company Information
Table 101. Ascent Pharmaceuticals Description and Business Overview
Table 102. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product
Table 104. Ascent Pharmaceuticals Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Zydus Icosapent Ethyl Drugs Product
Table 109. Zydus Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Strides Pharma Icosapent Ethyl Drugs Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. PuraCap Pharmaceuticals Company Information
Table 116. PuraCap Pharmaceuticals Description and Business Overview
Table 117. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 119. PuraCap Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharma Icosapent Ethyl Drugs Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Mankind Pharma Company Information
Table 126. Mankind Pharma Description and Business Overview
Table 127. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Mankind Pharma Icosapent Ethyl Drugs Product
Table 129. Mankind Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Company Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. GLW Pharma Company Information
Table 136. GLW Pharma Description and Business Overview
Table 137. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. GLW Pharma Icosapent Ethyl Drugs Product
Table 139. GLW Pharma Recent Developments/Updates
Table 140. Sichuan Gowell Pharmaceutical Company Information
Table 141. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 142. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product
Table 144. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Qilu Pharmaceutical Icosapent Ethyl Drugs Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Suncadia Medicine Company Information
Table 151. Chengdu Suncadia Medicine Description and Business Overview
Table 152. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product
Table 154. Chengdu Suncadia Medicine Recent Developments/Updates
Table 155. Jiangsu Wangao Pharmaceutical Company Information
Table 156. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 157. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product
Table 159. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 160. Humanwell Puracap Pharmaceuticals Company Information
Table 161. Humanwell Puracap Pharmaceuticals Description and Business Overview
Table 162. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 164. Humanwell Puracap Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Icosapent Ethyl Drugs Distributors List
Table 168. Icosapent Ethyl Drugs Customers List
Table 169. Icosapent Ethyl Drugs Market Trends
Table 170. Icosapent Ethyl Drugs Market Drivers
Table 171. Icosapent Ethyl Drugs Market Challenges
Table 172. Icosapent Ethyl Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Icosapent Ethyl Drugs
Figure 2. Global Icosapent Ethyl Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Icosapent Ethyl Drugs Market Share by Type: 2025 & 2032
Figure 4. Single Drug Product Picture
Figure 5. Combination Drug Product Picture
Figure 6. Global Icosapent Ethyl Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Icosapent Ethyl Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Icosapent Ethyl Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Icosapent Ethyl Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Icosapent Ethyl Drugs Sales (K Units), 2021–2032
Figure 14. Global Icosapent Ethyl Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Icosapent Ethyl Drugs Report Years Considered
Figure 16. Icosapent Ethyl Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Icosapent Ethyl Drugs Players: Market Share by Revenue in Icosapent Ethyl Drugs in 2025
Figure 19. Icosapent Ethyl Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Icosapent Ethyl Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Icosapent Ethyl Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Icosapent Ethyl Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Icosapent Ethyl Drugs by Type (2021–2032)
Figure 54. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Icosapent Ethyl Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Icosapent Ethyl Drugs by Application (2021–2032)
Figure 57. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Icosapent Ethyl Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Icosapent Ethyl Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Icosapent Ethyl Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Icosapent Ethyl Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Icosapent Ethyl Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Icosapent Ethyl Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Icosapent Ethyl Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Icosapent Ethyl Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Icosapent Ethyl Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Icosapent Ethyl Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Icosapent Ethyl Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Icosapent Ethyl Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Icosapent Ethyl Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Icosapent Ethyl Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Icosapent Ethyl Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Icosapent Ethyl Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Icosapent Ethyl Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Icosapent Ethyl Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Icosapent Ethyl Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Icosapent Ethyl Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Icosapent Ethyl Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Icosapent Ethyl Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Icosapent Ethyl Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Icosapent Ethyl Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Icosapent Ethyl Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Icosapent Ethyl Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Woodward Pharma Company Information
Table 71. Woodward Pharma Description and Business Overview
Table 72. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Woodward Pharma Icosapent Ethyl Drugs Product
Table 74. Woodward Pharma Recent Developments/Updates
Table 75. Amarin Pharmaceuticals Company Information
Table 76. Amarin Pharmaceuticals Description and Business Overview
Table 77. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product
Table 79. Amarin Pharmaceuticals Recent Developments/Updates
Table 80. Apotex Company Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Apotex Icosapent Ethyl Drugs Product
Table 84. Apotex Recent Developments/Updates
Table 85. Hikma Company Information
Table 86. Hikma Description and Business Overview
Table 87. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hikma Icosapent Ethyl Drugs Product
Table 89. Hikma Recent Developments/Updates
Table 90. Dr. Reddy's Laboratories Company Information
Table 91. Dr. Reddy's Laboratories Description and Business Overview
Table 92. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product
Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Icosapent Ethyl Drugs Product
Table 99. Teva Recent Developments/Updates
Table 100. Ascent Pharmaceuticals Company Information
Table 101. Ascent Pharmaceuticals Description and Business Overview
Table 102. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product
Table 104. Ascent Pharmaceuticals Recent Developments/Updates
Table 105. Zydus Company Information
Table 106. Zydus Description and Business Overview
Table 107. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Zydus Icosapent Ethyl Drugs Product
Table 109. Zydus Recent Developments/Updates
Table 110. Strides Pharma Company Information
Table 111. Strides Pharma Description and Business Overview
Table 112. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Strides Pharma Icosapent Ethyl Drugs Product
Table 114. Strides Pharma Recent Developments/Updates
Table 115. PuraCap Pharmaceuticals Company Information
Table 116. PuraCap Pharmaceuticals Description and Business Overview
Table 117. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 119. PuraCap Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharma Company Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharma Icosapent Ethyl Drugs Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Mankind Pharma Company Information
Table 126. Mankind Pharma Description and Business Overview
Table 127. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Mankind Pharma Icosapent Ethyl Drugs Product
Table 129. Mankind Pharma Recent Developments/Updates
Table 130. Amneal Pharmaceuticals Company Information
Table 131. Amneal Pharmaceuticals Description and Business Overview
Table 132. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product
Table 134. Amneal Pharmaceuticals Recent Developments/Updates
Table 135. GLW Pharma Company Information
Table 136. GLW Pharma Description and Business Overview
Table 137. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. GLW Pharma Icosapent Ethyl Drugs Product
Table 139. GLW Pharma Recent Developments/Updates
Table 140. Sichuan Gowell Pharmaceutical Company Information
Table 141. Sichuan Gowell Pharmaceutical Description and Business Overview
Table 142. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product
Table 144. Sichuan Gowell Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Qilu Pharmaceutical Icosapent Ethyl Drugs Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Suncadia Medicine Company Information
Table 151. Chengdu Suncadia Medicine Description and Business Overview
Table 152. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product
Table 154. Chengdu Suncadia Medicine Recent Developments/Updates
Table 155. Jiangsu Wangao Pharmaceutical Company Information
Table 156. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 157. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product
Table 159. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 160. Humanwell Puracap Pharmaceuticals Company Information
Table 161. Humanwell Puracap Pharmaceuticals Description and Business Overview
Table 162. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product
Table 164. Humanwell Puracap Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Icosapent Ethyl Drugs Distributors List
Table 168. Icosapent Ethyl Drugs Customers List
Table 169. Icosapent Ethyl Drugs Market Trends
Table 170. Icosapent Ethyl Drugs Market Drivers
Table 171. Icosapent Ethyl Drugs Market Challenges
Table 172. Icosapent Ethyl Drugs Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Icosapent Ethyl Drugs
Figure 2. Global Icosapent Ethyl Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Icosapent Ethyl Drugs Market Share by Type: 2025 & 2032
Figure 4. Single Drug Product Picture
Figure 5. Combination Drug Product Picture
Figure 6. Global Icosapent Ethyl Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Icosapent Ethyl Drugs Market Share by Application: 2025 & 2032
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Icosapent Ethyl Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Icosapent Ethyl Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Icosapent Ethyl Drugs Sales (K Units), 2021–2032
Figure 14. Global Icosapent Ethyl Drugs Average Price (US$/Unit), 2021–2032
Figure 15. Icosapent Ethyl Drugs Report Years Considered
Figure 16. Icosapent Ethyl Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Icosapent Ethyl Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Icosapent Ethyl Drugs Players: Market Share by Revenue in Icosapent Ethyl Drugs in 2025
Figure 19. Icosapent Ethyl Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Icosapent Ethyl Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 23. United States Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Icosapent Ethyl Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Icosapent Ethyl Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Icosapent Ethyl Drugs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Icosapent Ethyl Drugs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Icosapent Ethyl Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Icosapent Ethyl Drugs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Icosapent Ethyl Drugs by Type (2021–2032)
Figure 54. Global Icosapent Ethyl Drugs Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Icosapent Ethyl Drugs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Icosapent Ethyl Drugs by Application (2021–2032)
Figure 57. Global Icosapent Ethyl Drugs Price (US$/Unit) by Application (2021–2032)
Figure 58. Icosapent Ethyl Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232